Filing Flows

Filing Flows › Health Care › Mobia Medical (MOBI)

Mobia Medical (MOBI) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Mobia Medical (MOBI) Q3 2026 earnings results →

Q3 2026 Revenue up 73% year over year to $15.6M · 111¢ of every $1 of revenue lost · operating margin -118.7%

Mobia Medical made $15.6M in Q3 2026 (+73% Y/Y). Operating margin -118.7%, net loss $17.3M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$15.6M
Year over year+73%
Operating margin-118.7%
Net earnings−$17.3M
Operating cash flow−$12.9M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $15.6M in Q3 2026, up 73% year over year and up 16% from the previous quarter.

Gross margin was 83.2%, up 3.6 points from a year earlier. Operating costs exceeded revenue by $18.5M, an operating margin of -118.7%. Operating expenses grew 71% against revenue growth of 73%. The fastest-growing cost line was SG&A (+72%). The quarter ended with a net loss of $17.3M, narrower than the previous quarter's $21.0M loss.

Operating cash flow was −$12.9M. Non-cash charges added back $177K of depreciation and amortization and $2.6M of share-based compensation. Working capital and other items added $1.7M. Capital expenditures of $58K exceeded it, leaving free cash flow of −$13.0M.

Quarterly history

Mobia Medical revenue by quarterMobia Medical revenue by quarter$12.1MQ1 2026$13.5MQ2 2026$15.6MQ3 2026
Mobia Medical net earnings by quarterMobia Medical net earnings by quarter−$17.7MQ1 2026−$21.0MQ2 2026−$17.3MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 5, 2026$15.6M+73%-118.7%−$17.3M−$12.9M
Q2 202610-QAug 11, 2026$13.5M+102%-132.7%−$21.0M−$15.7M
Q1 202610-QJun 4, 2026$12.1M+113%-140.3%−$17.7M−$17.7M

Charts

Mobia Medical: revenue growth, year over year and quarter over quarterMobia Medical: revenue growth, year over year and quarter over quarterY/YQ/Q+113%Q1 2026+102%+12%Q2 2026+73%+16%Q3 2026
Latest (Q3 2026): Y/Y +73%, Q/Q +16%.
Mobia Medical: profit against cash, quarter by quarterMobia Medical: profit against cash, quarter by quarterNet incomeOperating cash flow−$10.7M−$9.7MQ1 2025−$10.5M−$11.0MQ2 2025−$11.4M−$11.6MQ3 2025−$17.7M−$17.7MQ1 2026−$21.0M−$15.7MQ2 2026−$17.3M−$12.9MQ3 2026
Latest (Q3 2026): Net income −$17.3M, Operating cash flow −$12.9M.
Mobia Medical in its industry: growth against margin (111 companies, SIC 3841)Mobia Medical in its industry: growth against margin (111 companies, SIC 3841)revenue growth, year over year →↑ operating marginmedian +10%median -9%MDLNMMMSYKBSXBDXBAXSOLVRMDDXCMWSTMMEDPODDGMEDTFXICUIMMSIIARTPENHAETNDMEMBCIRTCATECGKOSOFIXINSPNVCRUFPTATRCBVSAORTPRCTTCMDARAYANGOKIDSSKINLMATHTFLMDXGCERSSIBNTMCISTIMINFUBBNXKMTSOSURANIKDCTHRCELSGHTIRMDXTNTLUNGNPCEPDEXTELACARLLNSRSIAPYXSSIICVRXCLPTKRMDTLSIPROFSNWVCTSOIDXGUTMDRVPSNOAPREMNEPHDRIOVVOSBTCYNXGLMDAIMDNCPMINONE.SRTSSINTIVFNMTCNSPRAURXXAIRLUCDTNONINBSRNXTVTAKUSAQICUVYCOHRGNCNSYPLSEPETVFEMYOSRHCODXOBIORDGLPAVMGUTSMOBI (+73%, -100%)
Surgical & Medical Instruments & Apparatus; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Mobia Medical

Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.

In its own words, from its 8-K, filed Aug 11, 2026.

Mobia Medical against its Surgical & Medical Instruments & Apparatus peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +73% against the peers' median +5%. Operating margin: -118.7% against the peers' median 13.3%.

CompanyQuarterRevenueY/YOp. margin
MOBI Mobia MedicalQ3 2026$15.6M+73%-118.7%
MDLN MedlineQ3 2026$7.9B+10%6.4%
MMM 3MQ3 2026$6.6B+1%23.7%
SYK StrykerQ3 2026$6.5B+8%15.9%
BSX Boston ScientificQ3 2026$5.1B+1%16.1%
BDX Becton DickinsonQ3 FY26$5.0B+5%13.3%
BAX Baxter InternationalQ3 2026$3.0B+5%7.6%
SOLV SolventumQ3 2026$1.9B-7%3.5%
RMD ResMedQ1 FY27$1.4B+6%32.0%

Source: Mobia Medical 10-Q on SEC EDGAR · CIK 1489993 · Surgical & Medical Instruments & Apparatus

Guidance and outlook

Mobia Medical: what its forward-looking statements are about (10-Q filed 2026-11-05)Mobia Medical: what its forward-looking statements are about (10-Q filed 2026-11-05)Other17Demand9Costs6Capital spending3
35 statements; tone +0.40 (−1 all cautious, +1 all confident); 4 hedged.
Mobia Medical: outlook statements against the filing beforeMobia Medical: outlook statements against the filing beforeConfident18Cautious4

13F: who owns MOBI and who is buying

Largest holders of MOBI (13F)Largest holders of MOBI (13F)SR One Capital Management, LP$26.6MAvidity Partners Management LP$10.7MDeerfield Management Company, L.P…$9.0Mabrdn$7.8MPerceptive Advisors LLC$7.0MVanguard Capital Management LLC$6.0MRock Springs Capital Management LP$5.6MBalyasny Asset Management L.P.$5.2MIntegral Health Asset Management,…$3.4MSchonfeld Strategic Advisors LLC$2.4M

More on MOBI

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results

Compare MOBI with

中文版:Mobia Medical(MOBI)财报

Español · Français